TP53 and breast neoplasm: In the subcutaneous breast tumor model, immunohistochemical staining also revealed that GEM@PLGA@HM markedly reduced PI3K, AKT, and MAPK expression and elevated p53 expression when compared to PLGA@HM (Fig. S12).